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Objectives: This study was carried out to: 1) explore the views of pharmacists in Nigeria 
on the extension of prescribing authority to them and determine their willingness to be 
prescribers 2) identify the potential facilitators and barriers to introducing pharmacist 
prescribing in Nigeria.  
Method: An online cross-sectional survey was conducted from August to October 2014 
among 775 pharmacists recruited from the Facebook group of the Pharmaceutical 
Society of Nigeria using a simple random technique. The questionnaire used for the 
survey was developed based on the review of the literature and previous qualitative 
studies conducted in Nigeria. The instrument was evaluated for content validity by two 
external pharmacy practice researchers and the reliability of items assessed using 
internal consistency tests. Data obtained from the survey were entered into SPSS v.22 
and descriptive statistics were generated. Relationships between variables were 
evaluated using the chi-square test and p < 0.05 was considered statistically significant.   
Key findings: The response rate was 40.6% (315/775). Three hundred and six (97.1%) 
respondents agreed that pharmacists should be given prescribing authority. Of these 
306, 295 (96.4%) were willing to be prescribers and just over half of them (148/295; 
50.2%) would prefer to prescribe in collaboration with medical doctors. Of those willing 
to be prescribers, 285 (96.6%) reported that they would need additional training. The 
most perceived areas of training needed were in the principles of differential diagnosis 
(81.4%), pathophysiology of diseases (74.0%) and interpretation of laboratory results 
(68.1%). Respondents identified increasing patients’ access to care (308/315; 97.8%) 
and better utilisation of pharmacists’ skills (307/315; 97.5%) as the most likely facilitators 
to pharmacist prescribing in Nigeria. On the other hand, resistance from the medical 
doctors (299/315; 94.9%) and pharmacists’ inadequate skills in diagnosis (255/315; 
81.0%) were perceived as the most likely barriers. 
Conclusion: Pharmacist prescribing represents an opportunity to promote patients’ 
access to care and the utilisation of pharmacists’ skills in Nigeria. The majority of 
pharmacists showed a positive attitude towards pharmacist prescribing and were willing 
to be prescribers. The findings of this study could potentially contribute to future medicine 
prescribing policy and pharmacy practice in Nigeria. 





Prescribing to patients has traditionally been under the professional domain of doctors 
and dentists, until the introduction of non-medical prescribing (NMP) in some countries 
which allowed non-medical professionals including nurses, pharmacists, optometrists 
and physiotherapists to prescribe medicines.[1,2] Nurse prescribing is the most prevalent  
form of NMP worldwide.  Available data shows that Nurses have been authorised to 
prescribe in 22 countries including the United States of America (USA), United Kingdom 
(UK), Australia, New Zealand, Canada, Sweden, the Republic of Ireland, South Africa, 
Botswana, Kenya and Uganda.[1] Pharmacists are legally allowed to prescribe medicines 
in the United States, United Kingdom, Canada, New Zealand and Israel.[2,3]  However, a 
2009 global survey of hospital pharmacy practice revealed that hospital pharmacists in 
20 countries are involved in the prescribing of medicines under certain local 
arrangements in emergency situations.[4]  For instance, in Anguilla and Argentina, 
designated pharmacists are allowed to prescribe narcotic analgesics to cancer patients 
in an emergency.[5]  
There are different models of pharmacist prescribing including independent, 
supplementary and collaborative prescribing models.[2] In the independent prescribing 
model, the pharmacist is independently and legally responsible for the assessment of 
patients with diagnosed or undiagnosed conditions and for his or her prescribing 
decisions.  Supplementary and collaborative prescribing models have similar features as 
the prescribing pharmacist prescribes in partnership with an independent prescriber 
usually a doctor or dentist, who makes the diagnosis and initial treatment decisions.[2] 
However, in the supplementary prescribing model, prescribing by pharmacists including 
modification and continuation of therapy is achieved using a patient-specific clinical 
management plan (CMP). The CMP is agreed by the independent and supplementary 
prescribers as well as the patient. The scope of prescribing authority accorded to 
pharmacists differs from one country to another. For example, in the UK, pharmacists 
can prescribe any medicine within their area of competence except cocaine, dipipanone 
and diamorphine for treating addiction,[6] while in  Alberta, Canada, pharmacists with 
additional prescribing authorization can prescribe any medicines within their area of 
competence except those covered under the Controlled Drugs and Substances Act 
including narcotics.[7, 8]  
Despite the challenges associated with the implementation of pharmacist prescribing 
including opposition from doctors and limited evidence to demonstrate its effectiveness,[9] 
it is gradually being accepted and implemented internationally. For example, in Canada, 
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pharmacist prescribing started in 2007 in the Alberta province and by 2012 all the 
provinces except Quebec had granted prescribing authority to pharmacists.[8] 
Furthermore,  pharmacists in many countries, where pharmacist prescribing has not 
been legalised are keen in taking on an extended role in prescribing. For example, in an 
Australian survey, 83.9% of the 2592 pharmacists who participated in the study were in 
favour of a prescribing authority being extended to them.[10] The increase in the 
international recognition of pharmacist prescribing has been facilitated by the desire to 
ensure prompt patient access to prescription medicines and better utilisation of 
pharmacists’ skills. [9] Various stakeholders including doctors, pharmacists, patients, and 
policymakers have reported an increase in patients’ access to treatment as a result of 
NMP.[11,12] In addition, pharmacists have reported a positive impact on their role to 
include: enhanced job satisfaction; better use of their clinical skills; integration of 
pharmacists into the patient management team and more autonomy and responsibility 
in patient management as a result of pharmacist prescribing.[11,13] 
In Nigeria, only medical doctors, dentists and some designated nurses and community 
health workers in community-based primary health centres (PHCs) have the legal right 
to prescribe medicines.[14] However, prescribing by nurses and community health 
workers has been reported to be inappropriate for a number of reasons including lack of 
adherence to treatment guidelines and their inadequate knowledge of medicines.[15,16] 
For example, prescribing antibiotics for the treatment of viral respiratory infections has 
been reported to be common. [15,16] 
In hospitals in Nigeria, the general out-patient departments (GOPDs) serve as the entry 
points for most patients seeking medical help because of the lack of doctors in PHCs.[3,17] 
These GOPDs function more or less like the general practitioner (GP) practices in the 
UK. Typically, a doctor in a GOPD in Nigeria has approximately 40 – 50 patient 
consultations per day because of the shortage of doctors.[17,18]  In addition, more than 
50% of patients visiting GOPDs wait for between one to three hours to see a doctor. [17,18]    
As a result, access to prescription medicines in Nigeria can be seriously affected by the 
shortage of medical prescribers (4 doctors per 10,000 people compared with 28 doctors 
per 10,000 people in the UK) including general practitioners and specialist physicians 
and long waiting times in hospitals.[15,19] 
Pharmacists in Nigeria are highly educated professionals with expertise in medicines 
management. However, their expertise is not used effectively as their roles have not 
been expanded to a more clinical one. They mainly perform the traditional role of 
dispensing, which could be handled by suitably trained pharmacy technicians as in other 
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countries such as the UK.[20] Pharmacists in Nigeria have shown a willingness for 
expanded clinical roles including prescribing.[3,21] Our qualitative study involving semi-
structured interviews with 43 Nigerian stakeholders including policymakers, doctors, 
pharmacists and patient group representatives revealed  strong support for the 
introduction of pharmacist prescribing in Nigeria by participants who were not doctors 
especially pharmacists.[3] However, the findings of this study cannot be generalised 
because of the small sample size.  Therefore the aim of this study was to: 1) explore the 
views of pharmacists in Nigeria on the extension of prescribing authority to them and 
determine their willingness to be prescribers and 2) identify the potential facilitators and 
barriers to introducing pharmacist prescribing in Nigeria 
Methods 
Study design  
A cross-sectional survey was conducted from September to October 2014 among 
pharmacists in Nigeria using an online self-completion questionnaire as the data 
collection instrument. 
Ethical approval 
Ethical approval for this study was granted by the School of Healthcare Research Ethics 
Committee, University of Leeds, UK and the Plateau State Specialist Hospital Health 
Research Ethics Committee, Nigeria. 
Recruitment of participants 
Participants were recruited from the Facebook group of the Pharmaceutical Society of 
Nigeria (PSN). PSN is the professional body for pharmacists in Nigeria. PSN’s Facebook 
group had 5,214 members at the time of this survey. Participants for both the pilot and 
main survey were recruited using a simple random technique. To achieve a random 
sample, a list of the members of the Facebook group was retrieved in alphabetical order 
and then numbered serially. Microsoft Excel 2010 was used to generate a list of non-
repeated random numbers which were applied to the PSN’s Facebook group list to 
recruit participants for the online survey. A   sample of 695 pharmacists determined using 
the sample size formula for descriptive studies described by Eng,[22] were invited to 




The questionnaire was informed by the review of the literature and findings of our 
qualitative studies conducted with Nigerian stakeholders in relation to extending 
pharmacists’ clinical roles to include prescribing.[3, 10, 23] It was evaluated for content 
validity through an iterative review process by two external academic pharmacy practice 
researchers. The first page of the online survey contained an introductory statement 
relating to the study. In addition, it contained information on consent and implications of 
participating in the study.  Those who agreed to continue with the survey moved unto the 
next page of the survey which contained the survey questions. The survey was 
anonymised and consisted of 62 items which were divided into 3 sections.   
The first section of the questionnaire had 8 items and sought to obtain anonymous 
demographic details of respondents including gender, years of experience, area and 
place of practice. These data are needed to enable the statistical classification of 
respondents’ views and test for relationship between participants’ demographics and 
views. The second section sought participants’ views on clinical pharmacy practice in 
Nigeria and had 9 items. The third section contained 45 items measuring respondents’ 
views on pharmacist prescribing in Nigeria including their preferred model, willingness to 
be prescribers, perceived areas of training needs and potential facilitators and barrier. 
Depending on the survey item, respondents were either asked to respond yes/no or 
complete a five point Likert scale (strongly agree, agree, unsure, disagree and strongly 
disagree) to indicate their level of agreement with a statement. 
Piloting of questionnaire 
The questionnaire was piloted in August 2014 among a separate sample of 80 
pharmacists recruited from the PSN’s Facebook group as described above for the main 
sample.  These pharmacists were sent a message through Facebook inviting them to 
participate in the online pilot survey. Participants were asked to provide feedback to the 
researcher on any aspect of the survey including style, length, access to the online 
questionnaire and difficulty faced when completing the online survey. A follow-up 
message was sent after two weeks thanking those who had completed the survey and 
requesting those who were yet to participate to please do so.  
Of the 80 pharmacists that were contacted for the pilot survey, 41 participants returned 
completed surveys. Reliability testing of the questionnaire was carried out using 
Chronbach’s alpha (α). The internal consistency of the 25 items measuring the facilitators 
and barriers to granting prescribing authority to pharmacists in Nigeria was determined 
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using SPSS and that gave an α value of 0.745. The Kuder-Richardson reliability 
coefficients (KR-20) of the 13 items measuring respondents’ perceived areas of training 
need for pharmacist prescribing was 0.892. Based on the responses to the pilot, no 
further changes to the questionnaire were found to be necessary. Hence, the data 
collected were included in the overall results of this study. This was considered 
acceptable as participants were included in the pilot study based on the same inclusion 
criteria and sampling technique used for the main survey.  
The main survey 
The 695 pharmacists identified for the main survey were invited through a generic 
recruitment mail sent to their Facebook inbox. The mail contained the link to the survey 
hosted by the Bristol Online Survey (BOS).  
Reminders were sent to all research participants, two weeks after they received the initial 
invitation mailing. An additional three weeks was allowed to collect responses following 
the reminder. The survey was closed at the end of October 2014. 
Data analysis 
The data collected in this study were imported from the BOS system into the IBM SPSS 
version 22 for data management and analysis. Descriptive statistics generated using 
SPSS were used to represent the demographic characteristics of respondents and their 
views including those on prescribing. Relationships between two variables were 
evaluated using chi-square test. In tests involving variables in which data were obtained 
on the five-point Likert scale, respondents’ views were rescaled into three categories 
(strongly agree/agree, unsure and disagree/strongly disagree). This rescaling was done 
because of the small sample size of the study. In addition, re-categorising respondents’ 
views into three (as opposed to five) in chi-square analysis minimises the probability of 
making type 2 error (failing to reject the null hypothesis even though there is a difference 
between the groups in the population) which is usually manifested when the sample size 
is small or when considering a small sub-group within a large survey. Furthermore, 
Fisher’s exact test was used to determine statistical difference between groups in 
instances where the groups were small, particularly when the numbers of counts per cell 
in the contingency table were less than 5 in more than 20% of the cells. In all the Chi-





Response rate  
Of the 695 pharmacists contacted for the main survey (which excluded the 80 already 
included in the pilot), 316 attempted to complete the survey but only 274 surveys were 
completely filled while the remaining 42 were partially completed. The 42 partially 
completed surveys were unusable and therefore excluded from the study.  Hence, the 
response rate for the main study was 39.4% (274/695). Adding the pilot surveys [pilot 
response rate of 51.3% (41/80)] to those obtained in the main study yielded an overall 
response rate of 40.6% (315/775).  
Demographics 
Table 1 presents a summary of the demographic characteristics of respondents. The 
majority of respondents were male (197/315; 62.5%) and a third had between 6-10 years 
of experience (105/315; 33.3%) as pharmacists. Twenty eight (8.9%) respondents held 
a master’s degree in clinical pharmacy. The majority of respondents were hospital 
pharmacists (190/315; 60.3%).  
Views on pharmacist prescribing and willingness to be prescribers 
The results of this study revealed   strong support for an extended role in prescribing for 
pharmacists in Nigeria. Three hundred and six (97.1%) respondents agreed that 
pharmacists should be given the authority to prescribe medicines. Of these, 96.4% 
(295/315) were willing to be prescribers. There was no significant difference (p = 0.547) 
between willingness of hospital (95.8%) and community (97.7%) pharmacists to be 
prescribers.  
Of those willing to be prescribers, half (148/295) would prefer to prescribe in collaboration 
with medical doctors (who would diagnose) whilst 10.5 % (31/295) preferred independent 
prescribing. Just over one-third of these respondents (111/295; 37.6%) would prefer a 
combination of collaborative and independent prescribing. Prescribing from a limited 
drug formulary was the least preferred model of prescribing among respondents (5/295, 
1.7%). The results showed no significant difference (p = 0.491) between hospital and 
community pharmacists in their preference for any of the prescribing models 
Perceived areas of training needs 
The majority of respondents (285/295; 96.6%) who were willing to be prescribers 
reported that they would need additional training in order to become prescribers. In 
addition, all of these respondents strongly agreed or agreed that postgraduate clinical 
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courses should be developed to prepare pharmacists for prescribing. The most 
perceived areas of training need were in the principles of differential diagnosis (81.4%), 
pathophysiology of diseases (74.0%) and interpreting laboratory results (68.1%). 
Medication adherence (25.6%) and communication skills (35.1%) were reported as 
areas of least training need (Figure 1). 
Potential facilitators and barriers to pharmacist prescribing 
Respondents’ views in relation to the potential facilitators and barriers to granting 
prescribing authority to pharmacists in Nigeria are presented in Table 2. Respondents 
identified increasing patients’ access to care (308/315; 97.8%), better utilisation of 
pharmacists’ skills (307/315; 97.5%) and ensuring effective use of the limited human 
resources for health (290/315; 92.1%) as the most likely facilitators. On the other hand, 
resistance from the medical doctors (299/315; 94.9%), pharmacists’ inadequate skills in 
diagnosis (255/315; 81.0%) and shortage of pharmacists (220/315; 69.8%) were 
perceived as the most likely barriers. 
 Discussion 
Overall, pharmacists showed a positive attitude towards the introduction of pharmacist 
prescribing in Nigeria. The majority of them supported it and were willing to be 
prescribers themselves. These findings confirm the qualitative study we conducted with 
Nigerian stakeholders where the majority of the pharmacists interviewed were strongly 
supportive of the granting of prescribing authority to them.[2]   
We consider this to be the first national survey that investigated pharmacists’ views on 
the extension of their clinical roles to include prescribing in Nigeria. The initial design of 
the project was to recruit participants who were representatives of the pharmacists’ 
population in Nigeria in order to ensure statistical generalisation of the study findings. 
However, it was not possible to obtain the email addresses of all the registered 
pharmacists (about 17,000) on the Pharmacists’ Council of Nigeria list as many do not 
have their emails on the councils’ database. Therefore, the population in which the 
respondents of this survey were drawn was a biased one because it excluded Nigerian 
pharmacists who were not members of the Facebook group of PSN. About 60% of those 
contacted for this survey did not participate in the study. This is likely to introduce a non-
response bias in the findings of this survey. Also, a large proportion of those that 
responded to the survey were hospital pharmacists, this could be a potential source of 
bias as respondents of this study might have been those more interested in pharmacist 
prescribing.  Despite these limitations, this study has provided many avenues for future 
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research including a larger national survey that would generate generalizable data and 
to investigate how best to prepare Nigerian pharmacists for a potential role in prescribing. 
Also, future surveys should investigate the views of other key stakeholders including 
medical doctors and patients, who are major players in driving medicines policies in 
Nigeria.  
The strong support for pharmacist prescribing seen in this study is unsurprising in view 
of pharmacists’ aspirations for better utilisation of their skills and enhanced clinical 
autonomy in their practice. These desires are believed to be achievable within the scope 
of practice of the pharmacist prescriber.[3, 11] Therefore, such perception would have 
influenced pharmacists’ support for prescribing. 
Many facilitators to pharmacist prescribing identified in this survey were linked to its 
potential benefits. A key benefit identified in this research is the potential of pharmacist 
prescribing to increase patients’ access to care. Increasing patients’ access to care is 
one of the key policy objectives of non-medical prescribing including pharmacist 
prescribing in countries where it is being practiced including the UK and Canada.[1] 
Patients in some UK studies have reported an increase in access to care including 
perceived reduction in appointment delays as a result of nonmedical prescribing.[11, 24] 
This would be of great benefit to patients in Nigeria considering that many patients lack 
access to medical care as a result of shortage of medical practitioners. In addition, 
pharmacists’ involvement in prescribing could potentially reduce doctors’ workload or 
permit doctors to deal with more complex cases leaving routine or patients with pre-
diagnosed, long term conditions to be seen by the prescribing pharmacists. 
Medical resistance was perceived by the majority of respondents (94.9%) as the most 
likely barrier to pharmacist prescribing. However, medical resistance is unlikely if 
pharmacists prescribe in collaboration with doctors. This is because the doctor still 
maintains the overall control of the prescribing process. In addition, the doctor in a 
collaborative prescribing arrangement sees the pharmacist as someone who enhances 
or complements the doctors’ role and not doctors’ substitute. In contrast, independent 
pharmacist prescribing may be viewed by doctors as an encroachment into their territory 
and therefore could attract resistance from doctors. Although the majority of participants 
of this survey including hospital and community pharmacists reported that they would 
prefer to prescribe in collaboration with doctors, collaborative prescribing is more likely 
to be successful within hospital settings in the Nigerian context. Unlike hospital 
pharmacists, there is currently no system in place to foster collaborative working 
relationships between doctors and community pharmacists. In addition, community 
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pharmacists in Nigeria have no access to patients’ medical records maintained by 
hospitals. As a result, these factors are likely to present a challenge to community 
pharmacist collaborative prescribing. A limited form of independent prescribing using 
approved formularies or standard treatment guidelines for minor conditions could be 
more appropriate for community pharmacy settings in Nigeria. This was the type of 
prescribing model authorised for community pharmacists in South Africa in order to fill 
geographical gaps in relation to access to medical prescriber in rural settings.[25] Previous 
studies in Nigeria have advocated a policy change to allow community pharmacists to 
treat minor disease conditions.[26,27] Hence, utilising Nigerian community pharmacists in 
a similar manner to South Africa, offers an opportunity to increase patients access to 
care particularly in communities underserved by primary care facilities. 
The perceived areas of training need identified in this study including training in the 
principles of differential diagnosis, confirm respondents’ concerns that pharmacists’ 
inadequate skills in diagnosis and clinical assessment could be potential barriers to 
introducing pharmacist prescribing in Nigeria. In many countries where pharmacists are 
legally allowed to prescribe, those intending to be prescribers are required to undergo 
additional training to enhance their competence in prescribing. Although training 
requirements vary across countries, the UK training model appears to be well established   
and has been evaluated for its appropriateness in meeting the training needs of 
prescribers. Many supplementary and independent pharmacist prescribers in the UK 
have reported that the prescribing courses they attended provided them with relevant 
knowledge and skills for their roles. In addition, the period of learning and practice under 
a medical prescriber was highly appreciated. [28, 29] The UK training curriculum for non-
medical prescribers is based on a single framework that ensures that all prescribers 
irrespective of their professional background develop comparable set of 
competencies.[30] Developing similar competencies framework and using it to inform the 
training of prescribers in Nigeria would be beneficial.  Such a competency framework 
would ensure that all prescribers in Nigeria attain a minimum level of competency in 
which they can safely and competently prescribe medicines within their jurisdiction. 
Conclusion 
Generally, pharmacists showed a positive attitude towards pharmacist prescribing as the 
majority of them supported it and were willing to be prescribers. However, many 
pharmacists noted that they will need additional training particularly in the aspects of the 
principles of differential diagnosis and pathophysiology of diseases in order to take on a 
prescribing role.  This study has provided many avenues for future research including 
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how best to prepare Nigerian pharmacists for a potential role in prescribing. Many 
pharmacists also viewed pharmacist prescribing as an opportunity to promote patients’ 
access to care and the utilisation of pharmacists’ skills in Nigeria. This finding has the 
potential to shape future medicine prescribing policy and pharmacy practice in Nigeria. 
Nevertheless, a number of barriers to introducing pharmacist prescribing in Nigeria were 
identified including medical opposition and pharmacists’ inadequate skills in clinical 
assessment and diagnosis. 
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Pharmacist prescribing will increase patients’ access to care 308 (97.8) 2 (0.6) 5 (1.6) 
Pharmacist prescribing will enable better use of pharmacists’ professional skills 307 (97.5) 3 (1.0) 5 (1.6) 
There will be resistance to pharmacist prescribing by the medical doctors 299 (94.9) 4 (1.3) 12 (3.8) 
Pharmacist prescribing will ensure effective use of the limited human resources in the health sector 290 (92.1)  13 (4.1) 12 (3.8) 
Pharmacist prescribing will reduce doctors’ workload 273 (86.7) 20 (6.3) 22 (7.0) 
Pharmacist prescribing will save healthcare cost for the government. 271 (86.0) 32 (10.2) 12 (3.8) 
Pharmacists’ skills in making diagnoses are limited 255 (81.0) 17 (5.4) 43 (13.7) 
Pharmacist prescribing will minimise the current illegal supply of ‘Prescription Only Medicines’ without 
a prescription in Nigeria 
246 (78.1) 51 (16.2) 18 (5.7) 
There are inadequate number of pharmacists in the country to do additional roles 220 (69.8) 20 (6.3) 75 (23.8) 
 Pharmacists lack access to patients’ clinical data 208 (66.0) 21 (6.7) 86 (27.3) 
Pharmacists’ training in clinical assessment is limited 192 (61.0) 26 (8.3) 97 (30.8) 
Pharmacists lack time to take on additional roles 165 (52.4) 20 (6.3) 130 (41.3) 
Pharmacists lack confidence to take on clinical roles 141 (44.8)  23 (7.3) 151 (47.9) 
There are inadequate facilities within community pharmacist to allow pharmacist prescribing 115 (36.5) 31 (9.8) 169 (53.7) 
Pharmacist prescribing will only happen if technicians are further trained to take on some of the supply 
roles of pharmacists 
108 (34.3) 51 (16.2) 156 (49.5) 
Pharmacists have negative attitude toward taking up clinical roles 106 (33.7) 34 (10.8) 175 (55.6) 
Pharmacists have a close working relationship with doctors in patient care 89 (28.3) 32 (10.2) 194 (61.6) 
Pharmacists will have commercial interest in prescribing 79 (25.1) 69 (21.9) 167 (53.0) 
There will be conflict of interest with pharmacists acting as both prescribers and dispensers 61 (19.4) 55 (17.5) 199 (63.2) 
The government is interested in developing pharmacists’ clinical roles 45 (14.3) 127 (40.3) 143 (45.4) 
Pharmacist prescribing will create confusion among the public as to the role of doctors and pharmacists 33 (10.5) 38 (12.1) 244 (77.5) 
Pharmacist prescribing will increase the likelihood for prescribing errors 27 (8.6) 31 (9.8) 257 (81.6) 
Pharmacist prescribing will reduce the quality of care the patient receives 20 (6.3) 9 (2.9) 286 (90.8) 
Pharmacist prescribing will not be accepted by patients 7 (2.2) 11 (3.5) 297 (94.3) 
Pharmacist prescribing will be more expensive for the patient 6 (1.9) 14 (4.4) 295 (93.7) 
SA/A: Strongly agree/Agree; D/SD: Disagree/Strongly disagree
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